Selling a healthcare practice is not a routine business transaction. It is a regulated, multi-step process where structure, documentation, and timing directly influence both value and closing certainty. For most physicians, dentists, and healthcare operators, this is a once-in-a-career event involving years—if not decades—of built equity.

The more useful question is not whether legal counsel is technically required. It is whether the transaction is being managed with the level of precision required by sophisticated buyers, lenders, and investors.

In today’s market—particularly in transactions involving private equity-backed platforms, MSO/DSO structures, or multi-site practices—that standard is high.

Why Healthcare Transactions Are Structurally Different

Healthcare transactions operate within a framework that extends well beyond basic commercial dealmaking. Even relatively straightforward practice sales can raise issues that do not exist in other industries.

Depending on the structure and jurisdiction, transactions may involve:

• State-specific restrictions on ownership, licensure, and fee-splitting
• Corporate practice of medicine or dentistry considerations
• Medicare and Medicaid enrollment and change-of-ownership implications
• Fraud and abuse considerations in certain compensation or referral structures
• Separation of clinical operations from management entities (MSO models)
• Multiple interdependent agreements governing operations, compensation, and real estate
• Third-party approvals or notifications involving landlords, lenders, and payors

Not every transaction implicates all of these issues. But many involve enough of them that the margin for error narrows quickly.

A buyer evaluating a healthcare platform is not simply acquiring revenue—they are underwriting compliance, sustainability, and scalability. That reality shapes how diligence is conducted, how documents are drafted, and how risk is allocated.

Is Legal Counsel Actually Required?

From a purely technical standpoint, no—there is no universal rule requiring a seller to retain legal counsel to complete a practice sale.

In practice, however, that distinction is not particularly meaningful.

Most of the terms that determine the true outcome of a transaction are not captured in the headline purchase price. They are embedded in the structure of the deal and the language of the agreements.

These include:

• How purchase price is paid and allocated for tax purposes
• What liabilities are retained or transferred
• How post-closing compensation is structured
• What restrictions apply to the seller after closing
• How risk is shared between the parties

Without experienced healthcare-focused counsel, these elements are often accepted rather than negotiated—and frequently not fully understood until later in the process.

Where Legal Counsel Directly Impacts Transaction Outcomes

1. Transaction Structure

Structure is one of the earliest decisions in a transaction—and one of the most consequential.

Common structures include asset sales, equity sales, mergers, and MSO-based arrangements. Each has different implications for:

• Tax treatment and after-tax proceeds
• Liability exposure (pre- and post-closing)
• Transferability of contracts and payor relationships
• Licensing and regulatory compliance
• Post-closing control and governance

In healthcare, structure is not purely elective. It must align with state law, licensing requirements, and, in some cases, corporate practice restrictions.

For example, a structure that appears economically attractive may create complications around provider enrollments or contract assignments. Similarly, certain compensation or management arrangements may require careful analysis to ensure compliance with applicable regulations.

These issues are significantly easier to address before the transaction framework is set. Once a buyer has modeled the deal and issued a letter of intent, structural flexibility becomes more limited.

2. Letter of Intent (LOI) Discipline

The LOI is often underestimated. While it is typically described as “non-binding,” it establishes the economic and structural baseline for the transaction.

Key terms typically addressed in an LOI include:

• Total purchase price and form of consideration
• Cash at closing versus rollover equity
• Earnouts or contingent payments
• Working capital expectations
• Exclusivity periods
• Timeline and process assumptions

Ambiguity at this stage often benefits the buyer. If key terms—such as EBITDA definitions or add-back assumptions—are not clearly defined, they are revisited during diligence, often to the seller’s disadvantage.

A well-structured LOI does not eliminate negotiation, but it creates discipline. It aligns expectations early and reduces the likelihood of material changes later in the process.

3. Diligence Preparation and Management

Diligence is where many transactions encounter friction.

Buyers in healthcare transactions typically conduct a multi-layered review that goes well beyond financial statements. This often includes:

• Billing practices and reimbursement trends
• Payor participation and provider credentialing
• Employment and independent contractor arrangements
• Compliance policies and historical risk areas
• Real estate terms and lease assignability
• Ownership structures and financial relationships

The quality of the seller’s preparation directly affects how this process unfolds.

Common issues that arise during diligence include:

• Inconsistent financial reporting or unsupported add-backs
• Outdated or incomplete employment agreements
• Leases that restrict assignment or change of control
• Gaps in compliance documentation
• Misalignment between operational reality and documented structure

When these issues are identified late, buyers often respond by:

• Reducing purchase price
• Expanding indemnification obligations
• Introducing escrows or holdbacks
• Delaying closing timelines

Legal counsel plays a central role in organizing disclosures, identifying risks early, and ensuring that information presented during diligence aligns with the representations made in the transaction documents.

4. Definitive Agreements and Risk Allocation

The purchase agreement and related documents are where the transaction is actually defined.

While sellers often focus on valuation, experienced buyers focus on risk allocation. This is reflected in provisions such as:

• Representations and warranties
• Indemnification structure (caps, baskets, survival periods)
• Disclosure schedules
• Conditions to closing
• Restrictive covenants
• Earnout mechanics and performance metrics
• Post-closing employment or management arrangements

In healthcare transactions, these provisions may also intersect with regulatory considerations. For example:

• Compensation structures may need to align with fair market value principles
• Management arrangements must be carefully structured in MSO models
• Restrictive covenants must be enforceable under applicable state law

Poorly negotiated or imprecisely drafted agreements can create long-term exposure. It is not uncommon for sellers to discover post-closing obligations or limitations that were not fully appreciated during negotiations.

5. Third-Party Consents and Closing Coordination

A signed purchase agreement does not guarantee a successful closing.

Healthcare transactions frequently require coordination with third parties, including:

• Landlords (lease assignments or new leases)
• Lenders (payoff letters, consents, or new financing arrangements)
• Payors (notifications, re-credentialing, or assignment restrictions)
• Licensing boards or regulatory bodies
• Medicare and Medicaid enrollment systems

These elements are often on the critical path to closing. If they are not identified and managed early, they can delay—or in some cases prevent—completion of the transaction.

Legal oversight helps ensure that these requirements are anticipated, tracked, and resolved in coordination with the broader deal timeline.

Where Sellers Encounter Avoidable Risk

In an effort to reduce transaction costs, some sellers rely on:

• Template-based agreements
• General business attorneys without healthcare specialization
• Broker-led processes without independent legal review

While this approach may appear efficient, it often introduces structural risk—particularly in transactions involving sophisticated buyers.

Common outcomes include:

• Acceptance of buyer-favorable terms without full analysis
• Misalignment between deal structure and regulatory requirements
• Incomplete or inconsistent documentation
• Late-stage diligence issues that weaken negotiating position
• Increased likelihood of retrading or delay

These risks are amplified in transactions involving:

• Multi-location practices
• Ancillary service lines
• Complex payor mixes
• Private equity or MSO/DSO buyers

In these settings, buyers are typically supported by experienced legal and financial teams. Proceeding without comparable representation creates an imbalance that is difficult to overcome later in the process.

The Role of Legal Counsel with Business Acumen

A healthcare practice sale is not purely a legal exercise or a financial one. The two are closely connected.

Effective transaction management requires alignment across:

• Legal structure and documentation
• Financial performance and earnings normalization
• Tax planning and proceeds optimization
• Operational realities of the practice

For example:

• EBITDA adjustments must be defensible to lenders and buyers
• Deal structure should reflect both tax considerations and regulatory constraints
• Employment and compensation arrangements must align with both business objectives and legal requirements

When these elements are handled in isolation, inconsistencies emerge. These inconsistencies are often identified during diligence, when the seller has the least flexibility to respond.

Morgan Advisory Group approaches transactions with legal counsel grounded in a strong understanding of financial and operational dynamics, advising healthcare professionals and investors across the full context in which deals actually occur. This perspective is particularly relevant in transactions involving institutional buyers, where alignment across disciplines is expected.

A More Practical Framing of the Question

Instead of asking:

“Do I need a lawyer to sell my practice?”

A more accurate question is:

“Is this transaction being managed at the level required for its size, complexity, and regulatory profile?”

If the answer is no, the consequences are rarely theoretical. They typically take one or more of the following forms:

• Purchase price reductions during diligence
• Expanded indemnification and post-closing liability
• Delayed closing timelines
• Failed transactions
• Post-closing disputes over compensation or obligations

These outcomes are not uncommon. They are often the result of insufficient preparation or misaligned advisory at the outset.

Final Takeaway

Selling a healthcare practice is a significant financial and professional milestone. The objective is not simply to reach an agreement. It is to complete a transaction that accurately reflects the value of the business while managing risk and preserving future flexibility.

Legal counsel with a strong understanding of the business and financial dynamics of a transaction plays a central role in achieving that outcome.

While not technically required in every transaction, experienced healthcare-focused counsel is often a practical necessity in deals of meaningful size or complexity.

Schedule a Confidential Consultation

If you are evaluating a potential sale, reviewing a letter of intent, or preparing your practice for market, a structured, transaction-focused approach is critical.

Morgan Advisory Group advises physicians, dentists, and healthcare investors on practice sales, recapitalizations, and MSO/DSO transactions. We provide integrated legal, financial, and strategic guidance from initial planning through closing.

A disciplined process at the outset materially improves both outcome and certainty at closing.

Schedule a confidential consultation with us today.